Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Reported mortalities and morbidities of therapeutic procedures for liver tumors vary between studies, because of different designs and small sample sizes. We investigated the mortalities and complication rates for hepatectomy, radiofrequency ablation (RFA), and trans-catheter arterial embolization (TAE) for hepatocellular carcinoma (HCC) in a large sample, using a nationwide Japanese database (the Diagnosis Procedure Combination database).
Data from the Diagnosis Procedure Combination database were analyzed for July 1 to December 31, 2007 and the same period in 2008. We identified 54,145 patients with HCC who underwent hepatectomy (n = 5,270), RFA (n = 11,688), or TAE (n = 37,187). In-hospital mortality and morbidity were analyzed for each procedure. The relationships between mortality and factors including patient characteristics and procedural backgrounds were assessed.
In-hospital mortalities associated with hepatectomy, RFA, and TAE were 2.6 % [95 % confidence interval (CI) 2.2–3.1], 0.3 % (0.2–0.4), and 1.0 % (0.9–1.1), and post-procedural complication rates were 14.5 % (13.5–15.5), 4.5 % (4.2–4.9), and 4.5 % (4.3–4.7), respectively. Increased mortality following hepatectomy was significantly associated with older age, extended lobectomy (vs. partial hepatectomy; odds ratio [OR] 3.80, p < 0.001), lower hospital volume (OR 2.74, p < 0.001), and renal comorbidity (OR 3.01, p = 0.02). Older age and cardiac comorbidity (OR 5.14, p = 0.001) were significantly associated with RFA-related mortality, and lower hospital volume was significantly associated with TAE-related mortality (OR 1.60, p < 0.001).
Mortalities and morbidities associated with therapeutic procedures for liver tumors were acceptably low in Japan, but were affected by patient and institutional characteristics.
- Jemal, A, Murray, T, Ward, E, Samuels, A, Tiwari, RC, Ghafoor, A (2005) Cancer statistics, 2005. CA Cancer J Clin 55: pp. 10-30 CrossRef
- Kamangar, F, Dores, GM, Anderson, WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24: pp. 2137-2150 CrossRef
- Arii, S, Yamaoka, Y, Futagawa, S, Inoue, K, Kobayashi, K, Kojiro, M (2000) Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 32: pp. 1224-1229 CrossRef
- Fong Y, Sun RL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg. 1999;229:790–9 (discussion 799–800).
- Grazi, GL, Ercolani, G, Pierangeli, F, Gaudio, M, Cescon, M, Cavallari, A (2001) Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg 234: pp. 71-78 CrossRef
- Llovet, JM, Fuster, J, Bruix, J (1999) Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 30: pp. 1434-1440 CrossRef
- Takayama, T, Makuuchi, M, Hirohashi, S, Sakamoto, M, Yamamoto, J, Shimada, K (1998) Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology 28: pp. 1241-1246 CrossRef
- Abdalla, EK, Vauthey, JN, Ellis, LM, Ellis, V, Pollock, R, Broglio, KR (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239: pp. 818-825 CrossRef
- Choti, MA, Sitzmann, JV, Tiburi, MF, Sumetchotimetha, W, Rangsin, R, Schulick, RD (2002) Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235: pp. 759-766 CrossRef
- Fernandez FG, Drebin JA, Linehan DC, Dehdashti F, Siegel BA, Strasberg SM. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg. 2004;240:438–47 (discussion 447–50).
- Rossi, S, Stasi, M, Buscarini, E, Quaretti, P, Garbagnati, F, Squassante, L (1996) Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol 167: pp. 759-768
- Livraghi, T, Goldberg, SN, Lazzaroni, S, Meloni, F, Solbiati, L, Gazelle, GS (1999) Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 210: pp. 655-661
- Curley, SA, Izzo, F, Delrio, P, Ellis, LM, Granchi, J, Vallone, P (1999) Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 230: pp. 1-8 CrossRef
- Tateishi, R, Shiina, S, Teratani, T, Obi, S, Sato, S, Koike, Y (2005) Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 103: pp. 1201-1209 CrossRef
- Bruix, J, Sherman, M (2005) Management of hepatocellular carcinoma. Hepatology 42: pp. 1208-1236 CrossRef
- Chang, MH, You, SL, Chen, CJ, Liu, CJ, Lee, CM, Lin, SM (2009) Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J Natl Cancer Inst 101: pp. 1348-1355 CrossRef
- Llovet, JM, Bruix, J (2003) Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37: pp. 429-442 CrossRef
- Imamura H, Seyama Y, Kokudo N, Maema A, Sugawara Y, Sano K, et al. One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg. 2003;138:1198–206 (discussion 1206).
- Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg. 2002;236:397–406 (discussion 397–406).
- Sumitani, M, Uchida, K, Yasunaga, H, Horiguchi, H, Kusakabe, Y, Matsuda, S (2011) Prevalence of malignant hyperthermia and relationship with anesthetics in Japan: data from the diagnosis procedure combination database. Anesthesiology 114: pp. 84-90 CrossRef
- Yasunaga, H, Shi, Y, Takeuchi, M, Horiguchi, H, Hashimoto, H, Matsuda, S (2010) Measles-related hospitalizations and complications in Japan, 2007–2008. Intern Med 49: pp. 1965-1970 CrossRef
- Yasunaga, H, Yanaihara, H, Fuji, K, Horiguchi, H, Hashimoto, H, Matsuda, S (2010) Impact of hospital volume on postoperative complications and in-hospital mortality after renal surgery: data from the Japanese Diagnosis Procedure Combination Database. Urology 76: pp. 548-552 CrossRef
- Ikai, I, Arii, S, Okazaki, M, Okita, K, Omata, M, Kojiro, M (2007) Report of the 17th nationwide follow-up survey of primary liver cancer in Japan. Hepatol Res 37: pp. 676-691 CrossRef
- Belghiti, J, Regimbeau, JM, Durand, F, Kianmanesh, AR, Dondero, F, Terris, B (2002) Resection of hepatocellular carcinoma: a European experience on 328 cases. Hepatogastroenterology 49: pp. 41-46
- Biasco, G, Gallerani, E (2001) Treatment of liver metastases from colorectal cancer: what is the best approach today?. Dig Liver Dis 33: pp. 438-444 CrossRef
- Cromheecke, M, Jong, KP, Hoekstra, HJ (1999) Current treatment for colorectal cancer metastatic to the liver. Eur J Surg Oncol 25: pp. 451-463 CrossRef
- Poon, RT, Fan, ST (2004) Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome. Liver Transpl 10: pp. S39-S45 CrossRef
- Ruers, T, Bleichrodt, RP (2002) Treatment of liver metastases, an update on the possibilities and results. Eur J Cancer 38: pp. 1023-1033 CrossRef
- Vivarelli, M, Guglielmi, A, Ruzzenente, A, Cucchetti, A, Bellusci, R, Cordiano, C (2004) Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg 240: pp. 102-107 CrossRef
- Yoon, SS, Tanabe, KK (1998) Multidisciplinary management of metastatic colorectal cancer. Surg Oncol 7: pp. 197-207 CrossRef
- Kohn GP, Nikfarjam M. The effect of surgical volume and the provision of residency and fellowship training on complications of major hepatic resection. J Gastrointest Surg. 2010;14:1981–9.
- Bilchik, AJ, Wood, TF, Allegra, DP (2001) Radiofrequency ablation of unresectable hepatic malignancies: lessons learned. Oncologist 6: pp. 24-33 CrossRef
- Curley, SA, Izzo, F, Ellis, LM, Nicolas Vauthey, J, Vallone, P (2000) Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 232: pp. 381-391 CrossRef
- Baere, T, Risse, O, Kuoch, V, Dromain, C, Sengel, C, Smayra, T (2003) Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR Am J Roentgenol 181: pp. 695-700
- Giorgio, A, Tarantino, L, Stefano, G, Coppola, C, Ferraioli, G (2005) Complications after percutaneous saline-enhanced radiofrequency ablation of liver tumors: 3-year experience with 336 patients at a single center. AJR Am J Roentgenol 184: pp. 207-211
- Jansen, MC, Duijnhoven, FH, Hillegersberg, R, Rijken, A, Coevorden, F, Sijp, J (2005) Adverse effects of radiofrequency ablation of liver tumours in the Netherlands. Br J Surg 92: pp. 1248-1254 CrossRef
- Livraghi, T, Solbiati, L, Meloni, MF, Gazelle, GS, Halpern, EF, Goldberg, SN (2003) Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 226: pp. 441-451 CrossRef
- Wood, TF, Rose, DM, Chung, M, Allegra, DP, Foshag, LJ, Bilchik, AJ (2000) Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol 7: pp. 593-600
- Kasugai, H, Osaki, Y, Oka, H, Kudo, M, Seki, T (2007) Severe complications of radiofrequency ablation therapy for hepatocellular carcinoma: an analysis of 3,891 ablations in 2,614 patients. Oncology 72: pp. 72-75 CrossRef
- Marelli, L, Stigliano, R, Triantos, C, Senzolo, M, Cholongitas, E, Davies, N (2007) Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Interv Radiol 30: pp. 6-25 CrossRef
- Begg, CB, Cramer, LD, Hoskins, WJ, Brennan, MF (1998) Impact of hospital volume on operative mortality for major cancer surgery. JAMA 280: pp. 1747-1751 CrossRef
- Birkmeyer, JD, Siewers, AE, Finlayson, EV, Stukel, TA, Lucas, FL, Batista, I (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346: pp. 1128-1137 CrossRef
- Birkmeyer, JD, Stukel, TA, Siewers, AE, Goodney, PP, Wennberg, DE, Lucas, FL (2003) Surgeon volume and operative mortality in the United States. N Engl J Med 349: pp. 2117-2127 CrossRef
- Birkmeyer, JD, Sun, Y, Goldfaden, A, Birkmeyer, NJ, Stukel, TA (2006) Volume and process of care in high-risk cancer surgery. Cancer 106: pp. 2476-2481 CrossRef
- Kuwabara, K, Matsuda, S, Fushimi, K, Ishikawa, KB, Horiguchi, H, Fujimori, K (2009) Impact of hospital case volume on the quality of laparoscopic colectomy in Japan. J Gastrointest Surg 13: pp. 1619-1626 CrossRef
- Schrag, D, Cramer, LD, Bach, PB, Cohen, AM, Warren, JL, Begg, CB (2000) Influence of hospital procedure volume on outcomes following surgery for colon cancer. JAMA 284: pp. 3028-3035 CrossRef
- Benzoni, E, Cojutti, A, Lorenzin, D, Adani, GL, Baccarani, U, Favero, A (2007) Liver resective surgery: a multivariate analysis of postoperative outcome and complication. Langenbecks Arch Surg 392: pp. 45-54 CrossRef
- Delis, SG, Bakoyiannis, A, Dervenis, C, Tassopoulos, N (2009) Perioperative risk assessment for hepatocellular carcinoma by using the MELD score. J Gastrointest Surg 13: pp. 2268-2275 CrossRef
- Laurent, C, Sa Cunha, A, Couderc, P, Rullier, E, Saric, J (2003) Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases. Br J Surg 90: pp. 1131-1136 CrossRef
- Schiesser, M, Chen, JW, Maddern, GJ, Padbury, RT (2008) Perioperative morbidity affects long-term survival in patients following liver resection for colorectal metastases. J Gastrointest Surg 12: pp. 1054-1060 CrossRef
- Sim, HG, Ooi, LL (2003) Results of resections for hepatocellular carcinoma in a new hepatobiliary unit. ANZ J Surg 73: pp. 8-13 CrossRef
- Ziparo, V, Balducci, G, Lucandri, G, Mercantini, P, Giacomo, G, Fernandes, E (2002) Indications and results of resection for hepatocellular carcinoma. Eur J Surg Oncol 28: pp. 723-728 CrossRef
- Kiely, JM, Rilling, WS, Touzios, JG, Hieb, RA, Franco, J, Saeian, K (2006) Chemoembolization in patients at high risk: results and complications. J Vasc Interv Radiol 17: pp. 47-53 CrossRef
- Kothary N, Weintraub JL, Susman J, Rundback JH. Transarterial chemoembolization for primary hepatocellular carcinoma in patients at high risk. J Vasc Interv Radiol. 2007;18:1517–26 (quiz 1527).
- Pietrosi, G, Miraglia, R, Luca, A, Vizzini, GB, Fili, D, Riccardo, V (2009) Arterial chemoembolization/embolization and early complications after hepatocellular carcinoma treatment: a safe standardized protocol in selected patients with Child class A and B cirrhosis. J Vasc Interv Radiol 20: pp. 896-902 CrossRef
- Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients
Journal of Gastroenterology
Volume 47, Issue 10 , pp 1125-1133
- Cover Date
- Print ISSN
- Online ISSN
- Springer Japan
- Additional Links
- Liver tumor
- Hospital volume
- Nationwide database
- Industry Sectors
- Author Affiliations
- 1. Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan
- 2. Department of Health Management and Policy, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
- 3. Department of Preventive Medicine and Community Health, University of Occupational and Environmental Health, Fukuoka, Japan